IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL)
Date
2006-07Author
Del Giudice, I
Davis, Z
Matutes, E
Osuji, N
Parry-Jones, N
Morilla, A
Brito-Babapulle, V
Oscier, D
Catovsky, D
Type
Journal Article
Metadata
Show full item recordAbstract
B-prolymphocytic leukemia (B-PLL) is a rare disease with poor prognosis. To further characterize the biological features of this disease, we analyzed immunoglobulin heavy chain (IgVH) mutations, ZAP-70 and CD38 in 19 cases with de novo B-PLL. Immunoglobulin heavy chain genes analysis showed an unmutated pattern (> 98% homology to germ line) in 9/17 cases (53%), with 100% homology in eight. In the remaining, it ranged from 90 to 97.4%, with three cases slightly mutated (98 -95%) and five heavily mutated (< 95%). All B-PLL utilized members of VH3 (11/17) and VH4 (6/17) families, with V3-23, V4-59 and V4-34 gene accounting for more than half of them, regardless of mutational status. ZAP-70, assessed by flow cytometry, ranged from 1 to 91% cells, being >= 20% in 57% of cases. CD38 ranged from 1 to 99% (median 21%). There was no correlation between IgVH status and ZAP-70 or CD38 expression, but male gender and del(17p) were more common in the unmutated group. Neither IgVH mutations, CD38 expression nor del(17p) influenced patients’ outcome. Unexpectedly, ZAP-70+ B-PLL patients survived longer (40 months) than ZAP-70-B-PLL (8 months). B-PLL appears biologically heterogeneous regarding IgVH mutations, ZAP-70 and CD38 expression, showing a pattern distinct from that of other lymphoproliferative disorders.
Collections
Research team
Molecular Haematology (including Cytogenetics Group and Cell Markers)
Language
eng
License start date
2006-07
Citation
LEUKEMIA, 2006, 20 pp. 1231 - 1237